Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.09%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
9.81 Down 1.00(9.25%) 4:00PM EDT
|After Hours : 9.99 Up 0.18 (1.83%) 7:55PM EDT
Add to Portfolio
Prev Close:10.81
Open:10.85
Bid:9.72 x 500
Ask:10.04 x 200
1y Target Est:16.67
Beta:0.54
Earnings Date:May 6 - May 11 (Est.)
Day's Range:9.72 - 10.99
52wk Range:2.31 - 14.40
Volume:4,442,514
Avg Vol (3m):4,681,680
Market Cap:1.26B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPDown 9.25%1.26B
IMGNDown 11.04%762.92M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):821.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.13
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback